高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

Biotechnology :the science, the prod...

Evens, Ronald P.

Biotechnology :the science, the products, the government, the business /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Biotechnology :/ Ronald P. Evens.
其他題名:	the science, the products, the government, the business /
作者:	Evens, Ronald P.
出版者:	Boca Raton, FL :CRC Press, : c2020.,
版本:	1st ed.
面頁冊數:	xix, 182 p. :ill. ; : 25 cm.;
提要註:	"The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features comprehensive coverage of biotechnology science topics used in development and manufacturing, addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline, presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved"--
標題:	Legislation, Drug. -
ISBN:	9780367024673 (hard) :

Biotechnology :the science, the products, the government, the business /
Evens, Ronald P.

Biotechnology :the science, the products, the government, the business /Ronald P. Evens. - 1st ed. - Boca Raton, FL :CRC Press,c2020. - xix, 182 p. :ill. ;25 cm. - Drugs and the pharmaceutical sciences. - Drugs and the pharmaceutical sciences..

Includes bibliographical references (p. 161-172) and index.

"The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features comprehensive coverage of biotechnology science topics used in development and manufacturing, addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline, presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved"--

ISBN: 9780367024673 (hard) :NT5805

LCCN: 2020009451Subjects--Topical Terms:

351589
Legislation, Drug.

LC Class. No.: RS380 / .E94 2020

Dewey Class. No.: 615.1/9

National Library of Medicine Call No.: QV 778

Biotechnology :the science, the products, the government, the business /
LDR:01824cam a2200241 a 4500 001 337554
005 20210419111601.0
008 210428s2020 flua b 001 0 eng
010 $a 2020009451
020 $a 9780367024673 (hard) : $c NT5805
020 $a 9780429399299 (ebk.)
035 $a 00382529
040 $a KMU $d KMU
042 $a pcc
050 0 0 $a RS380 $b .E94 2020
060 0 0 $a QV 778
082 0 0 $a 615.1/9 $2 23
100 1 $2 97000 $a Evens, Ronald P. $3 283153
245 1 0 $a Biotechnology : $b the science, the products, the government, the business / $c Ronald P. Evens.
250 $a 1st ed.
260 $a Boca Raton, FL : $b CRC Press, $c c2020.
300 $a xix, 182 p. : $b ill. ; $c 25 cm.
490 1 $a Drugs and the pharmaceutical sciences
504 $a Includes bibliographical references (p. 161-172) and index.
520 $a "The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features comprehensive coverage of biotechnology science topics used in development and manufacturing, addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline, presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved"-- $c Provided by publisher.
650 2 2 $a Legislation, Drug. $3 351589
650 2 2 $2 96060 $a Drug Industry. $3 253574
650 1 2 $2 96060 $a Biotechnology. $3 214508
650 1 2 $2 96060 $a Technology, Pharmaceutical. $3 214507
650 0 $2 96060 $a Pharmaceutical biotechnology industry. $3 255820
650 0 $2 96060 $a Pharmaceutical biotechnology. $3 220259
830 0 $a Drugs and the pharmaceutical sciences. $3 464511